 |
|
UCF Nanoparticle Offers Promise for Treating Glaucoma
June 19, 2007A unique nanoparticle made in a laboratory at the University of Central Florida is proving promising as a drug delivery device for treating glaucoma, an eye disease that can cause blindness and affects millions of people worldwide.
"The nanoparticle can safely get past the blood-brain barrier making it an effective non-toxic tool for drug delivery," said Sudipta Seal, an engineering professor with appointments in UCF's Advanced Materials Processing and Analysis Center and the Nanoscience Technology Center.
The findings will be published in an article appearing in the June 28 issue of the Journal of Physical Chemistry C.
Seal and his colleagues from North Dakota State University note in the article that while barely 1-3 percent of existing glaucoma medicines penetrate into the eye, earlier experiments with nanoparticles have shown not only high penetration rates but also little patient discomfort. The miniscule size of the nanoparticles makes them less abrasive than some of the complex polymers now used in most eye drops.
Seal and his team created a specialized cerium oxide nanoparticle and bound it with a compound that has been shown to block the activity of an enzyme (hCAII) believed to play a central role in causing glaucoma.
The disease involves abnormally high pressure of the fluid inside the eye, which, if left untreated, can result in damage to the optic nerve and vision loss. High pressure occurs, in part, because of a buildup of carbon dioxide inside the eye, and the compound blocks the enzyme that produces carbon dioxide.
Seal and a team of collaborators including Sanku Mallik, of North Dakota State University, developed the research on using nanoparticles as a delivery mechanism for the compound after supervising a student summer project at UCF. Duke University undergraduate Serge Reshetnikov spent a summer studying nanoscience on UCF's Orlando campus as part of a Research Experience for Undergraduates (REU) project funded by the National Science Foundation. Reshetnikov started looking into the possibilities of using nanoparticles as drug delivery tools. Subsequent research with his advisors led to the specific application for glaucoma.
In their paper on the research, which was also supported by the National Science Foundation, Seal and Mallik note the results are "very promising" and that their nanoparticle configuration offers seemingly limitless possibilities as a non-toxic drug delivery tool.
University of Central Florida
Seal and his colleagues from North Dakota State University note in the article that while barely 1-3 percent of existing glaucoma medicines penetrate into the eye, earlier experiments with nanoparticles have shown not only high penetration rates but also little patient discomfort. The miniscule size of the nanoparticles makes them less abrasive than some of the complex polymers now used in most eye drops.
Seal and his team created a specialized cerium oxide nanoparticle and bound it with a compound that has been shown to block the activity of an enzyme (hCAII) believed to play a central role in causing glaucoma.
The disease involves abnormally high pressure of the fluid inside the eye, which, if left untreated, can result in damage to the optic nerve and vision loss. High pressure occurs, in part, because of a buildup of carbon dioxide inside the eye, and the compound blocks the enzyme that produces carbon dioxide.
Seal and a team of collaborators including Sanku Mallik, of North Dakota State University, developed the research on using nanoparticles as a delivery mechanism for the compound after supervising a student summer project at UCF. Duke University undergraduate Serge Reshetnikov spent a summer studying nanoscience on UCF's Orlando campus as part of a Research Experience for Undergraduates (REU) project funded by the National Science Foundation. Reshetnikov started looking into the possibilities of using nanoparticles as drug delivery tools. Subsequent research with his advisors led to the specific application for glaucoma.
In their paper on the research, which was also supported by the National Science Foundation, Seal and Mallik note the results are "very promising" and that their nanoparticle configuration offers seemingly limitless possibilities as a non-toxic drug delivery tool.
University of Central Florida
Glaucoma Current Events and Glaucoma News RSSMelatonin may save eyesight in inflammatory disease
Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology.
Eye conditions linked with obstructive sleep apnea
If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus. In the November issue of Mayo Clinic Proceedings, Mayo Clinic researchers outline several interesting associations between sleep disorders and eye disease.
Vision loss more common in people with diabetes
Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Medication slows progression of myopia in children
Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Glaucoma procedure now available at Mayo Clinic aims to prevent further eye damage
For the first time in Florida, patients with glaucoma have a new treatment option known as the Trabectome.
Case Western Reserve and Penn State investigators inhibit corneal inflammation
Researchers from the Case Western Reserve University School of Medicine and Penn State Hershey College of Medicine identified a novel therapeutic that reduces sterile inflammation within the cornea.
Glaucoma report points to increased costs
A new Centre for Eye Research Australia/ Access Economics report shows the cost of glaucoma will more than double in the next two decades.
'Fluorescent' cells give early warning for eye disease
Scientists at the University of Michigan have shown that their new metabolic imaging instrument can accurately detect eye disease at a very early stage.
Role identified for glaucoma gene and related signaling pathway
Researchers have found that a gene and a related signaling pathway play a role in the development of glaucoma, which is a common cause of visual impairment and blindness worldwide.
Cost of glaucoma medications may impact treatment
In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total.
More Glaucoma Current Events and Glaucoma News Articles
 | What Your Doctor May Not Tell You About(TM) Glaucoma: The Essential Treatments and Advances That Could Save Your Sight (What Your Doctor May Not Tell You About...) by Gregory K. Harmon, Nancy Intrator Most people can recite the warning signs of cancer and just about everybody knows the risk factors for heart disease. But how many people know the facts about glaucoma? Well, what you don't know might save your sight. Glaucoma is an insidious and painful disease that is often misunderstood, and ultimately can rob patients of their sight completely. Between three and four million Americans are... |
 | Shields' Textbook of Glaucoma This popular reference on glaucoma management now offers a more practical and clinically focused textbook for ophthalmologists and residents. Readers find new or extensively updated information on cellular and molecular biology of the eye, molecular genetics and classification of glaucomas, epidemiology and public health, screening and risk assessment, congenital and developmental glaucomas with... |
 | Glaucoma: Color Atlas & Synopsis of Clinical Ophtalmology (Wills Eye Series) by Douglas J. Rhee, Christopher J. Rapuano Quick reference and color atlases covering 5 sub-specialties in ophthalmology. Each book will cover the following areas: Epidemiology and Etiology; History Physical Examination; Differential Diagnosis;Laboratory and Special Examinations; Diagnosis; Prognosis;... |
 | A Patient's Guide to Glaucoma by Young H Kwon, John H Fingert, Emily C Greenlee The Patient's Guide to Glaucoma is a very useful educational resource. The authors have done an excellent job of covering the pertinent aspects of glaucoma from the patient's perspective. It provides more complete explanations of aspects of glaucoma care than any other presently available resource. It will be very helpful to patients who want more information about medications, laser,... |
| Cataract; Glaucoma and Other Eye Disorders : Prevention and Cure with Proven Natural Methods by Tobe; John H. | |
 | Bilberry & Lutein: The Vision Enhancers! Protect Against Cataracts, MacUlar Degeneration, Glaucoma, Retinopathy & Other Health Problems (Health lear (Health Learning Handbook) by Beth M. Ley Our eyes are perhaps our most delicate and sensitive organs. They are at high risk for damage, especially from UV rays and other causes of free radical damage. Cataracts afflict approximately 29% of Americans between 65 and 74 years of age. Age-related macular degeneration is the most common cause of severe visual impairment in older Americans. Approximately 1.7 million have decreased vision and... |
 | Heal Yourself of Anything: Example Glaucoma by Nancy Lynne Harris Nancy Lynne Harris, spiritual counselor and healer, tells how her nine-year-old son was healed of congenital glaucoma when she reversed her attitude toward a domineering (pressuring) person in her life. Nancy explains the spiritual healing process, which can be used to heal any illness. Your problems can become mental harmony disturbers because they bring negative words to your mind. By... |
 | Surgical Techniques in Ophthalmology Series: Glaucoma Surgery: Text with DVD (Surgical Techniques in Ophthalmology) by Teresa C. Chen Whether you're in training or an established practitioner, the brand-new Surgical Techniques in Ophthalmology Series features the essential information you need on a variety of surgical maneuvers in six subspecialty areas. Every author has been carefully selected for each title based on their experience and wealth of clinical expertise. And, each book is presented in a concise, templated format... |
 | Coping With Glaucoma by Edith Marks, Rita Mountauredes |
 | Clinical Pathways in Glaucoma by Thom Zimmerman, Karanjit Kooner With the goal of simplifying the diagnosis and treatment process, Drs. Zimmerman and Kooner introduce Clinical Pathways in Glaucoma. This new decision-making guide offers 22 chapters on topics ranging from childhood and neovascular glaucoma to drug-induced glaucoma and management of glaucoma in pregnancy. Each chapter is consistently laid out in the same organized format: Definition,... |
| © 2008 BrightSurf.com |